Beyond market trends, investors looking for superior returns explore the world of stock picking. The right selections can be a powerful driver for wealth accumulation.
The price of Ocular Therapeutix Inc (NASDAQ: OCUL) closed at $11.58 in the last session, down -0.69% from day before closing price of $11.66. In other words, the price has decreased by -$0.69 from its previous closing price. On the day, 1.44 million shares were traded. OCUL stock price reached its highest trading level at $11.815 during the session, while it also had its lowest trading level at $11.49.
Ratios:
We take a closer look at OCUL’s different ratios to gain a better understanding of the stock. For the most recent quarter (mrq), Quick Ratio is recorded 10.14 and its Current Ratio is at 10.22. In the meantime, Its Debt-to-Equity ratio is 0.29 whereas as Long-Term Debt/Eq ratio is at 0.28.
On March 18, 2025, RBC Capital Mkts started tracking the stock assigning a Outperform rating and target price of $17.
On March 11, 2025, Needham started tracking the stock assigning a Buy rating and target price of $15.Needham initiated its Buy rating on March 11, 2025, with a $15 target price.
Insider Transactions:
An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on Jun 02 ’25 when Waheed Nadia sold 13,861 shares for $8.05 per share. The transaction valued at 111,581 led to the insider holds 206,805 shares of the business.
NADIA K. WAHEED bought 13,861 shares of OCUL for $111,524 on Jun 02 ’25. On May 23 ’25, another insider, Nayak Sanjay, who serves as the Chief Strategy Officer of the company, sold 1,862 shares for $7.17 each. As a result, the insider received 13,351 and left with 281,623 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, OCUL now has a Market Capitalization of 1844694016 and an Enterprise Value of 1571233920. For the stock, the TTM Price-to-Sale (P/S) ratio is 30.93 while its Price-to-Book (P/B) ratio in mrq is 6.94. Its current Enterprise Value per Revenue stands at 26.342 whereas that against EBITDA is -7.785.
Stock Price History:
The Beta on a monthly basis for OCUL is 1.50, which has changed by 0.48843193 over the last 52 weeks, in comparison to a change of 0.18569505 over the same period for the S&P500. Over the past 52 weeks, OCUL has reached a high of $12.35, while it has fallen to a 52-week low of $5.78. The 50-Day Moving Average of the stock is 21.07%, while the 200-Day Moving Average is calculated to be 33.17%.
Shares Statistics:
According to the various share statistics, OCUL traded on average about 2.27M shares per day over the past 3-months and 1706720 shares per day over the past 10 days. A total of 159.26M shares are outstanding, with a floating share count of 133.28M. Insiders hold about 16.33% of the company’s shares, while institutions hold 74.43% stake in the company. Shares short for OCUL as of 1752537600 were 14797351 with a Short Ratio of 6.52, compared to 1749772800 on 14421637. Therefore, it implies a Short% of Shares Outstanding of 14797351 and a Short% of Float of 9.33.
